期刊文献+

成纤维细胞生长因子受体2多态性与乳腺癌相关性研究 被引量:2

Relative research of FGFR2 Gene SNPs and breast neoplasm
下载PDF
导出
摘要 目的研究成纤维细胞生长因子受体2(FGFR2)基因单核苷酸多态性(SNP)与乳腺癌相关性。方法对280例乳腺癌患者及280例健康女性进行ASA-PCR检测,分析其三个位点(rs2912778、rs2981582、rs2981578)SNP与乳腺癌风险关系。结果三个位点(rs2912778、rs2981582、rs2981578)基因型分布在乳腺癌组和对照组中差异具有统计学意义(P<0.05);与病理资料进一步联系分析,除rs2912778在淋巴结转移方面野生型与变异型差异具有高度统计学意义(P<0.01)之外,其余三个位点野生型与变异型相比差异均无统计学意义(均P>0.05)。结论 FGFR2基因三个位点单核苷酸多态性可能与乳腺癌的发生有关。 Objective To investigate whether single nucleotide polymorphisms (SNP) of fibroblast growth receptor 2 (FGFR2) are associated with breast cancer risk. Methods In the present study of 280 breast cancer patients and 280 cancer-free controls, we tested three FGFR2 polymorphisms (rs2981582, rs2981578A/G and rs2912778) the method of ASAPCR. Results Differences were found in the genotypes between the breast neoplasm group and the control group of all loci (P 〈 0.05). Among three loci, except rs2912778 (P 〈 0.01) in FGFR2 was related to lymph node metastasis, any difference between wild-type and variant-type in clinical pathological factors were not found (all P 〉 0.05). Conclusion The findings indicate that genetic variants in FGFR2 may contribute to breast cancer occurrence.
出处 《中国医药导报》 CAS 2012年第22期13-15,19,共4页 China Medical Herald
关键词 成纤维细胞生长因子受体2 单核苷酸多态性 乳腺癌 Fibroblast growth factor receptor 2 Single nucleotide polymorphism Breast neoplasm
  • 引文网络
  • 相关文献

参考文献16

  • 1Dickson C,Spencer-Dene B,Dillon C,et al. Tyrosine kinase signalling in breast cancer:fibroblast growth factors and their receptors [J]. Breast Cancer Res ,2000,2(3) : 191-196.
  • 2Miriam SU ,Kerstin BM ,Karen AP,et al. FGFR2 variants and breast cancer risk:fine-scale mapping using African American studies and analysis of chromatin conformation [J]. Hum Mol Genet ,2009,18 (9) : 1692-1703.
  • 3Xuegong Z,Sylvia LA,Shereen E. Histone-acetylated control of fibrob- last growth factor receptor 2 intron 2 Polymorphisms and isoform Splic- ing in breast cancer [J]. Mol Endoerinol, 2009,23 (9) : 1397-1405.
  • 4Jirong L, Xiao-Ou S, Qiuyin C. Evaluation of breast cancer susceptibility loci in Chinese women [J]. Cancer Epidemiol Biomarkers Prev,2010,19 (9) :2357-2365.
  • 5Tannheimer SL,Rchemtulla A,Ethier SP. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE [J]. Breast Cancer Res, 2000,2 (4) : 311-320.
  • 6Bates CM. Role of fibroblast growth factor receptor signaling in kidney development [J]. Pediatr Nephrol, 2007,22 (3) : 343-349.
  • 7Parsa S,Ramasamy SK,De Langhe S,et al. Terminal end bud mainte- nance in mammary gland is dependent upon FGFR2b signaling [J]. Dev Bio1,2008,317( 1 ) : 121-131.
  • 8Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis [J]. Cytokine Growth Factor Rev, 2005,16 (2) : 179-186.
  • 9Kondo T,Zheng L,Liu W,et al. Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen- activated kinase pathway to modulate thyroid cancer progression [J]. Cancer Res, 2007,67 (11 ) :5461-5470.
  • 10Moffa AB ,Tannheimer SL ,Ethier SP. Transforming potential of alterna- tively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells [J]. Mol Cancer Res, 2004,2 ( 11 ) : 643-52.

同被引文献24

引证文献2

二级引证文献2

;
使用帮助 返回顶部